The Motley Fool Discussion Boards

Previous Page

Social Clubs / The World is Flat

URL:  https://boards.fool.com/fuma-thanks-for-your-background-thoughts-on-34231878.aspx

Subject:  Re: NASH thoughts Date:  6/18/2019  8:58 AM
Author:  2K10 Number:  235 of 252

Fuma -- thanks for your background thoughts on NASH.

I am in a Canadian company Theratechnologies (OTC: THERF) which is already treating HIV patients with fatty liver with EGRIFTA containing Tesamorelin so should have a decent safety profile.

This week they announced good results in trying to extend the label on Tesamorelin to NASH.

https://www.globenewswire.com/news-release/2019/06/17/186968...

The stock is down since the announcement so maybe the market sees similar business case as you do.

However Tesamorelin is not why I'm in THERF, I am hoping for commercial success of their HIV drug http://trogarzo.com/.

I don't have the deep background into pharma companies that you do. Have you ever looked at Theratechnologies?
Copyright 1996-2021 trademark and the "Fool" logo is a trademark of The Motley Fool, Inc. Contact Us